By Counterforce Health Team in Krystexxa (pegloticase) —

How Long Does It Take to Get Krystexxa (Pegloticase) Approved by Aetna (CVS Health) in New York? Timeline & Milestones

Answer Box: Getting Krystexxa Approved by Aetna in New York

Standard timeline: 15-30 days for initial prior authorization; 72 hours for expedited appeals through New York DFS if urgent. Key requirements: G6PD deficiency screening (negative), failed conventional therapy documentation, rheumatologist prescription, and methotrexate co-therapy unless contraindicated. First step: Contact your rheumatologist to submit prior authorization with complete lab work and treatment history to CVS Specialty Pharmacy.

Table of Contents

  1. What Affects Your Approval Timeline
  2. Pre-Submission Preparation (0-2 Days)
  3. Initial Review Process (1-5 Days)
  4. Additional Information Requests (1-7 Days)
  5. Decision Window & Outcomes
  6. If Denied: New York Appeal Options
  7. Renewal Cycles & Reauthorization
  8. Timeline Visual Guide
  9. Time-Saving Tips

What Affects Your Approval Timeline

Several factors determine how quickly Aetna approves Krystexxa (pegloticase) in New York:

Benefit Structure Impact:

  • Medical benefit (Part B): Faster processing through established J2507 billing codes
  • Pharmacy benefit: May require CVS Specialty routing, adding 2-3 days
  • Site of care requirements: Aetna implemented site-of-care precertification for Krystexxa effective November 2024

Documentation Completeness: The most common delays stem from missing required elements. Aetna's policy mandates specific documentation that, when incomplete, triggers automatic requests for additional information.

Prescriber Specialization: Requests from rheumatologists or gout specialists typically process faster than those requiring consultation verification.

Pre-Submission Preparation (0-2 Days)

Essential Documentation Checklist

Before your rheumatologist submits the prior authorization, gather these required elements:

Laboratory Requirements:

  • G6PD deficiency test results (must be negative)
  • Recent serum uric acid level (within 1 month, showing ≥6 mg/dL)
  • Historical uric acid trends demonstrating persistent elevation

Treatment History Documentation:

  • Failed conventional therapy records (minimum 3 months of allopurinol, febuxostat, or probenecid)
  • Intolerance or contraindication documentation for standard treatments
  • Discontinuation attestation for all oral urate-lowering medications

Clinical Information:

  • Chronic gout diagnosis with ICD-10 codes
  • Symptomatic presentation documentation
  • Age verification (must be 18+ years)

Methotrexate Co-Therapy:

  • MTX prescription with weekly dosing and folic acid
  • Clinical contraindication documentation if MTX cannot be used (liver disease, renal impairment, pregnancy)
Tip: Request all historical lab work and treatment records from previous providers early. Missing documentation from outside New York can add 5-10 days to your timeline.

Initial Review Process (1-5 Days)

Once your rheumatologist submits the complete prior authorization package:

Day 1-2: Administrative Review

  • CVS Specialty verifies member eligibility and benefit coverage
  • Initial screening for required documentation completeness
  • Assignment to clinical reviewer

Day 3-5: Clinical Review

  • Medical necessity assessment against Aetna's clinical criteria
  • Verification of failed prior therapies
  • G6PD and laboratory result validation

New York-Specific Considerations: New York's insurance regulations require insurers to make initial determinations within specific timeframes, though Aetna typically completes Krystexxa reviews faster than state maximums.

Additional Information Requests (1-7 Days)

If Aetna requests additional information, respond within 10 business days to avoid case closure:

Most Common Requests:

  • G6PD test clarification: Specific assay method or confirmation of negative result
  • Prior therapy details: Exact dosages, duration, and reason for discontinuation
  • Specialist consultation: Verification of rheumatology involvement
  • Methotrexate justification: Clinical rationale for co-therapy or contraindication

Rapid Response Strategy:

  • Designate one clinic staff member to handle all Aetna communications
  • Submit responses via Aetna's provider portal for fastest processing
  • Include a cover letter summarizing exactly what documentation is being provided

Decision Window & Outcomes

Typical Approval Timeline:

  • Complete submissions: 15-20 days
  • Incomplete submissions: 25-35 days (including additional information cycle)
  • Complex cases: Up to 45 days if peer-to-peer review is required

Reading Your Decision Letter:

  • Approved: Will include specific quantity limits, site of care requirements, and renewal date
  • Denied: Contains specific denial codes and required appeal information
  • Pending: Lists exactly what additional information is needed

If Denied: New York Appeal Options

New York provides robust appeal rights for Krystexxa denials:

Internal Appeals (First Level)

New York External Review

If internal appeals fail, New York's Department of Financial Services offers binding external review:

  • Deadline: 4 months after final internal denial
  • Expedited timeline: 72 hours for urgent cases; 24 hours for urgent drug denials
  • Cost: $25 fee (waived for financial hardship or Medicaid)
  • Success rate: Approximately 50% of external reviews favor patients

When to Request Expedited Review:

  • Rapid gout progression with joint destruction risk
  • Hospitalization due to severe gout flares
  • Physician attestation that delay could cause serious harm
From our advocates: We've seen Krystexxa appeals succeed when families included detailed documentation of failed prior therapies and clear evidence of G6PD testing. One effective strategy is citing Aetna's own clinical policy word-for-word in the appeal letter, which can increase overturn rates to 82% compared to generic appeals.

Getting Help with Appeals

  • Community Health Advocates: 888-614-5400 (free assistance for New Yorkers)
  • DFS External Appeal Portal: Online submission available
  • Counterforce Health: Specialized platform that helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals

Renewal Cycles & Reauthorization

Aetna requires annual reauthorization for Krystexxa with specific therapeutic response documentation:

Required Evidence of Benefit:

  • Serum uric acid consistently <6 mg/dL (no two consecutive readings above 6 mg/dL)
  • Reduction of tophi (documented by physical exam or imaging)
  • Decreased gout flare frequency or symptom improvement

Renewal Timeline:

  • Submit reauthorization 2-4 weeks before current approval expires
  • Standard processing: 10-15 days
  • Include updated lab work and clinical response documentation

Timeline Visual Guide

Phase Timeline Key Activities Potential Delays
Preparation 0-2 days Gather documentation, verify requirements Missing historical records
Submission 1 day Provider submits complete PA package Incomplete submissions
Initial Review 1-5 days Administrative and clinical assessment Complex cases requiring specialist review
Additional Info 1-7 days Response to information requests Slow provider response
Final Decision 15-30 days Approval/denial notification Peer-to-peer review needed
Internal Appeal 30-72 hours If denied, internal appeal process Incomplete appeal documentation
External Review 24-72 hours NY DFS expedited review if urgent Non-urgent cases take 30 days

Time-Saving Tips

Portal Optimization:

  • Use Aetna's provider portal (Availity/Novologix) for fastest submission
  • Upload all documents in a single PDF package
  • Include a detailed cover letter summarizing the clinical case

Bundled Evidence Strategy: Submit comprehensive documentation upfront rather than responding to multiple information requests:

  • Complete treatment timeline with exact dates and dosages
  • All relevant lab work from the past 12 months
  • Specialist consultation notes and recommendations

Direct Specialty Routing: Ensure your rheumatologist submits the request directly rather than routing through primary care, which can add 3-5 days to processing.

Proactive Communication:

  • Call Aetna's provider line to confirm receipt within 48 hours of submission
  • Request case number and reviewer contact information
  • Follow up weekly on pending cases

Common Denial Reasons & Solutions

Denial Reason Required Fix Documentation Needed
Missing G6PD test Submit negative G6PD screening Lab report with specific assay method
Insufficient prior therapy Document 3+ months failed treatment Prescription records, dosing, outcomes
No specialist involvement Rheumatology consultation Specialist evaluation and recommendation
Missing MTX co-therapy Justify MTX use or contraindication Prescription or clinical contraindication note

Frequently Asked Questions

How long does Aetna prior authorization take for Krystexxa in New York? Standard timeline is 15-30 days for complete submissions. Expedited appeals through New York DFS take 24-72 hours if urgent.

What if Krystexxa is non-formulary on my Aetna plan? You can request a formulary exception with medical necessity documentation. Success rates are higher when citing FDA approval and clinical guidelines.

Can I request expedited review in New York? Yes, if delay in treatment could cause serious harm. Include physician attestation of urgency and submit through New York DFS external appeal process.

Does step therapy apply if I failed treatments outside New York? Yes, Aetna accepts documentation of failed therapies from any location. Ensure you have complete treatment records with dates and outcomes.

What happens if my appeal is denied by Aetna? New York residents can request binding external review through the Department of Financial Services within 4 months of final internal denial.

Counterforce Health specializes in helping patients navigate complex prior authorization and appeal processes for specialty medications like Krystexxa. Our platform analyzes denial letters and creates targeted, evidence-backed appeals that speak directly to insurers' specific requirements, significantly improving approval rates for patients across New York.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage details. Insurance policies and state regulations may change; verify current requirements with official sources.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.